A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause

NCT04003389 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1831

Enrollment

INDUSTRY

Sponsor class

Conditions

Hot Flashes

Interventions

DRUG: fezolinetant
DRUG: placebo

Sponsor

Astellas Pharma Global Development, Inc.